Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Empagliflozin attenuates ISO-induced myocardial injury through PGC-1α-mediated mitochondrial biogenesis and improved fatty acid metabolism
Related
- Sotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM Mice
- Empagliflozin attenuates traumatic brain injury-induced atherosclerosis and norepinephrine-induced vascular smooth muscle cell responses
- Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio–Kidney–Metabolic Syndrome
- Impact of Empagliflozin on mRNA Levels of Cardiotrophin-1 and GDF-15 in Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Double-Blind Pilot Trial.
- Mitochondrial Biogenesis in Human Skeletal Muscle: High-Intensity Interval Training Versus Moderate-Intensity Continuous Training
BibTeX
@article{zhang2026empagliflozin,
title = {{Empagliflozin attenuates ISO-induced myocardial injury through PGC-1α-mediated mitochondrial biogenesis and improved fatty acid metabolism}},
author = {Chuyi Zhang and Xiandu Jin and Liping Wei and Yuhong Bian and Xin Qi},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-76620-8},
url = {https://www.nature.com/articles/s41598-026-76620-8},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Empagliflozin attenuates ISO-induced myocardial injury through PGC-1α-mediated mitochondrial biogenesis and improved fatty acid metabolism
AU - Chuyi Zhang
AU - Xiandu Jin
AU - Liping Wei
AU - Yuhong Bian
AU - Xin Qi
PY - 2026
DA - 2026/10/24
JO - Scientific Reports
DO - 10.1038/s41598-026-76620-8
UR - https://www.nature.com/articles/s41598-026-76620-8
SN - 2045-2322
ER -